Pure Global
NCT04511936

Microcurrent Stimulation for Dry Age-related Macular Degeneration

Microcurrent Stimulation Therapy for Dry Age-related Macular Degeneration (i-SIGHT): a Multicenter, Randomized, Double-masked, Clinical Device Trial
i-Lumen Scientific, Inc.·ClinicalTrials.gov·device·Device trialWithdrawn
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Dry Age-related Macular Degeneration
Drug/Device/Intervention
i-Lumen AMD
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
i-Lumen Scientific, Inc.
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2021
End date
Jan 31, 2023
Enrollment
0 participants
Primary outcome

Mean change from baseline in best-corrected distance visual acuity (CDVA) at one month timepoint.

Summary

Evaluate the safety and efficacy of microcurrent stimulation therapy for patients with dry
 age-related macular degeneration.

ICD-10 classifications
Peripheral retinal degenerationCorneal degenerationHereditary retinal dystrophyOptic atrophy in diseases classified elsewhereDisorders of choroid and retina
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04511936
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04511936 through Pure Global AI's free database. This phase not specified trial is sponsored by i-Lumen Scientific, Inc. and is currently Withdrawn. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 0 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.